October 11, 2001
Aventis Pharmaceuticals to Repeat Successful Breast
Cancer Patient Outreach Program
'Connection Cards'(TM) to Be Offered During Breast Cancer Awareness
Aventis Pharmaceuticals today
announced it will once again offer "Connection Cards"(TM), an outreach
program for breast cancer patients who are undergoing treatment. "Connection
Cards" are designed to help patients develop a support network of
institutions and professional experts. The program is available beginning
today to coincide with the start of National Breast Cancer Awareness Month.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000501/NYM197 )
According to the American Cancer Society, an estimated 192,200 new cases of
invasive breast cancer will be reported in women in the United States this
year. Women undergoing treatment may obtain the Connection Cards from their
The "Connection Cards" program includes 10 custom-designed, all-occasion
note cards and envelopes, a matching 30-minute prepaid long-distance phone
card, and a credit card-sized reference card containing toll-free numbers
and Web site addresses for nationally recognized breast cancer
organizations, including the American Cancer Society, Living Beyond Breast
Cancer, the National Alliance of Breast Cancer Organizations (NABCO), the
National Breast Cancer Coalition (NBCC), the Susan G. Komen Breast Cancer
Foundation and Y-ME National Breast Cancer Organization. The reference card
also provides a toll-free phone number and Internet address for "Living With
It," Aventis' new comprehensive support program for women with recurrent
breast cancer. With the completion of this year's program, nearly 100,000
Connection Cards kits will be distributed to patients.
"After a breast cancer diagnosis, every woman needs state-of-the-art care,
information to help her make the best decisions, connection to practical and
expert resources, and the support and comfort of family and friends," said
Amy S. Langer, executive director of the National Alliance of Breast Cancer
Organizations (NABCO) and a breast cancer survivor. "This program will offer
patients a welcome and meaningful gift."
Breast cancer is the most common cancer among women, excluding skin cancer,
and the second leading cause of cancer death among women in the United
States. The American Cancer Society estimates that in 2001 there will be
about 40,600 deaths from breast cancer in the United States.
About Aventis Pharmaceuticals
Aventis Pharmaceuticals conducts the U.S. business of Aventis Pharma AG.
With headquarters in Bridgewater, N.J., Aventis Pharmaceuticals focuses its
activities on important therapeutic areas such as cardiology, oncology,
anti-infectives, arthritis, allergy and respiratory, diabetes and central
Aventis Pharma AG is the pharmaceutical company of Aventis S.A. (NYSE: AVE)
. Aventis Pharma is dedicated to treating and preventing human disease
through the discovery, development, manufacture and sale of innovative
pharmaceutical products aimed at fulfilling unmet medical needs. The
corporate headquarters of Aventis Pharma is in Frankfurt, Germany. Aventis
Pharma is comprised of Aventis Pasteur, a world leader in vaccines,
headquartered in Lyon, France, and Aventis Behring, a world leader in
therapeutic proteins, headquartered in King of Prussia, Pa.
Aventis S.A., a world leader in pharmaceuticals and agriculture, is
headquartered in Strasbourg, France. The company employs approximately
92,500 people in more than 120 countries. Aventis was launched in December
1999 through the merger of Hoechst AG and Rhone-Poulenc S.A. To receive a
copy of this or any recent release, visit the Aventis Pharmaceuticals U.S.
Web site at http://www.aventispharma-us.com/ or call 800-207-8049.
Statements in this news release other than historical information are
forward-looking statements subject to risks and uncertainties. Actual
results could differ materially depending on factors such as the
availability of resources, the timing and effects of regulatory actions, the
strength of competition, the outcome of litigation, and the effectiveness of
patent protection. Additional information regarding risks and uncertainties
is set forth in the current Annual Report on Form 20-F of Aventis on file
with the Securities and Exchange Commission.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.